Telephone and Data Systems, Inc. (TDS)
NYSE: TDS · Real-Time Price · USD
38.03
-1.01 (-2.59%)
Aug 1, 2025, 4:00 PM - Market closed
Revance Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 4,856 | 4,964 | 5,160 | 5,413 | 5,329 | 5,225 | Upgrade | |
Revenue Growth (YoY) | -5.14% | -3.80% | -4.67% | 1.58% | 1.99% | 0.95% | Upgrade |
Cost of Revenue | 2,062 | 2,135 | 2,334 | 2,565 | 2,472 | 2,354 | Upgrade |
Gross Profit | 2,794 | 2,829 | 2,826 | 2,848 | 2,857 | 2,871 | Upgrade |
Selling, General & Admin | 1,722 | 1,721 | 1,753 | 1,768 | 1,677 | 1,681 | Upgrade |
Operating Expenses | 2,665 | 2,664 | 2,668 | 2,697 | 2,572 | 2,590 | Upgrade |
Operating Income | 129 | 165 | 158 | 151 | 285 | 281 | Upgrade |
Interest Expense | -283 | -279 | -244 | -174 | -232 | -168 | Upgrade |
Interest & Investment Income | 28 | 27 | 20 | 17 | 11 | 15 | Upgrade |
Earnings From Equity Investments | 159 | 164 | 159 | 159 | 182 | 181 | Upgrade |
Other Non Operating Income (Expenses) | 7 | 5 | 2 | 1 | -1 | -1 | Upgrade |
EBT Excluding Unusual Items | 40 | 82 | 95 | 154 | 245 | 308 | Upgrade |
Impairment of Goodwill | - | - | -547 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 2 | Upgrade |
Gain (Loss) on Sale of Assets | 39 | 35 | -25 | -26 | -24 | -22 | Upgrade |
Asset Writedown | -137 | -137 | - | -3 | - | - | Upgrade |
Pretax Income | -58 | -20 | -477 | 125 | 221 | 288 | Upgrade |
Income Tax Expense | -6 | 6 | 10 | 53 | 33 | 19 | Upgrade |
Earnings From Continuing Operations | -52 | -26 | -487 | 72 | 188 | 269 | Upgrade |
Minority Interest in Earnings | 2 | -2 | -13 | -10 | -32 | -43 | Upgrade |
Net Income | -50 | -28 | -500 | 62 | 156 | 226 | Upgrade |
Preferred Dividends & Other Adjustments | 69 | 69 | 69 | 69 | 39 | - | Upgrade |
Net Income to Common | -119 | -97 | -569 | -7 | 117 | 226 | Upgrade |
Net Income Growth | - | - | - | -60.26% | -30.97% | 86.78% | Upgrade |
Shares Outstanding (Basic) | 115 | 114 | 113 | 114 | 115 | 114 | Upgrade |
Shares Outstanding (Diluted) | 115 | 114 | 113 | 114 | 116 | 115 | Upgrade |
Shares Change (YoY) | 1.33% | 0.89% | -0.88% | -1.72% | 0.87% | -0.86% | Upgrade |
EPS (Basic) | -1.04 | -0.85 | -5.04 | -0.06 | 1.02 | 1.98 | Upgrade |
EPS (Diluted) | -1.04 | -0.85 | -5.04 | -0.07 | 1.00 | 1.94 | Upgrade |
EPS Growth | - | - | - | - | -48.43% | 87.45% | Upgrade |
Free Cash Flow | 329 | 261 | -69 | -6 | -28 | 194 | Upgrade |
Free Cash Flow Per Share | 2.87 | 2.29 | -0.61 | -0.05 | -0.24 | 1.69 | Upgrade |
Dividend Per Share | 0.160 | 0.310 | 0.740 | 0.720 | 0.700 | 0.680 | Upgrade |
Dividend Growth | -78.52% | -58.11% | 2.78% | 2.86% | 2.94% | 3.03% | Upgrade |
Gross Margin | 57.54% | 56.99% | 54.77% | 52.61% | 53.61% | 54.95% | Upgrade |
Operating Margin | 2.66% | 3.32% | 3.06% | 2.79% | 5.35% | 5.38% | Upgrade |
Profit Margin | -2.45% | -1.95% | -11.03% | -0.13% | 2.20% | 4.32% | Upgrade |
Free Cash Flow Margin | 6.78% | 5.26% | -1.34% | -0.11% | -0.53% | 3.71% | Upgrade |
EBITDA | 1,072 | 1,108 | 1,073 | 1,080 | 1,180 | 1,190 | Upgrade |
EBITDA Margin | 22.08% | 22.32% | 20.79% | 19.95% | 22.14% | 22.78% | Upgrade |
D&A For EBITDA | 943 | 943 | 915 | 929 | 895 | 909 | Upgrade |
EBIT | 129 | 165 | 158 | 151 | 285 | 281 | Upgrade |
EBIT Margin | 2.66% | 3.32% | 3.06% | 2.79% | 5.35% | 5.38% | Upgrade |
Effective Tax Rate | - | - | - | 42.40% | 14.93% | 6.60% | Upgrade |
Revenue as Reported | 4,856 | 4,964 | 5,160 | 5,413 | 5,329 | 5,225 | Upgrade |
Advertising Expenses | - | 207 | 208 | 196 | 203 | 213 | Upgrade |
Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.